Skip to main content
Theranostics logoLink to Theranostics
. 2021 Nov 10;11(20):10171–10172. doi: 10.7150/thno.68023

LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of Pancreatic Cancer: Erratum

Biao Zheng 1,2,*, Jianhua Qu 3,*, Kenoki Ohuchida 2,4,, Haimin Feng 2, Stephen Jun Fei Chong 3, Zilong Yan 5, Yicui Piao 6, Peng Liu 1, Nan Sheng 2, Daiki Eguchi 2, Takao Ohtsuka 2, Kazuhiro Mizumoto 2,7, Zhong Liu 1, Shazib Pervaiz 3,8,9, Peng Gong 1,10,, Masafumi Nakamura 2,
PMCID: PMC8581420  PMID: 34815810

In the original Figure 6C of our article 1, we mistakenly repeatedly used the LAMA4 shRNA-1 knockdown figure (Figure 6C, bottom middle) as the LAMA4 shRNA-2 knockdown figure (Figure 6C, bottom right) in the cell migration assay of CAFs. The Figure 6C should be corrected as follows. The figure corrected in this erratum does not influence any original conclusions in our study. We apologize for any inconvenience or misunderstanding that this error may have caused.

Figure 6.

Figure 6

C. Cell migration assay of CAFs was performed after non-contact co-culture with either WT pancreatic cancer cells or pancreatic cancer cells subjected to LAMA4 knockdown.

References

  • 1.Zheng B, Qu J, Ohuchida K, Feng H, Chong SJF, Yan Z, Piao Y, Liu P, Sheng N, Eguchi D, Ohtsuka T, Mizumoto K, Liu Z, Pervaiz S, Gong P, Nakamura M. LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of Pancreatic Cancer. Theranostics. 2020;10(22):10274–10289. doi: 10.7150/thno.47001. doi:10.7150/thno.47001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Theranostics are provided here courtesy of Ivyspring International Publisher

RESOURCES